During the past decade, Yale Medicine conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Yale Medicine" are "Inherited Mitochondrial Disease" (1 trials) and "Spinal Cord Injury" (1 trials). Many other conditions were trialed in "Yale Medicine" in a lesser frequency.

Most popular intervention types in "Yale Medicine" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "MT-3921" (1 trials), "Placebo" (1 trials) and "Vatiquinone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yale Medicine" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Yale Medicine". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in Yale Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yale Medicine, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Yale Medicine has several departments that took part in Clinical trials: "Yale Univ. School of Medicine - Dept. of Peds., Div. of Infectious Disease" - 14 trials, "Yale Univ School of Medicine / AIDS Program" - 13 trials, "Yale School of Medicine - Adult Congenital Heart Disease Program" - 2 trials, "Yale Dermatology Associates" - 2 trials, "Yale Pediatric Endocrinology Clinic" - 2 trials